Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Clinical trial NCT07648264 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07648264
- Sponsor
- CSL Behring
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-24
- Primary completion
- 2029-02-16
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.